Common Antidepressants Associated With Lower Bone Density

Test ticker

Monika Bauerlein,
CEO

Dear Reader,

The next few months are make-or-break for Mother Jones’ fundraising, and we need more online readers to pitch in than have been of late. In "It's Not a Crisis. This Is the New Normal," we take a level-headed look at the brutal economics of journalism, why investigative reporting like you get from us matters, and why we're optimistic we can grow our base of support in a big way—starting with hitting a huge $300,000 goal in just three weeks. Please learn more and donate if you can right now.

The next few months are make-or-break for Mother Jones’ fundraising. We need to raise $300,000 quickly, and we need more online readers to pitch in than have been. Please learn more in "It's Not a Crisis. This Is the New Normal," where we go into the brutal economics of journalism, and what makes Mother Jones unique and worth supporting if you can right now.

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Some antidepressants appear to be associated with an increased rate of bone loss in older men and women. These SSRIs (selective serotonin reuptake inhibitors), such as Prozac, Zoloft, and Paxil, treat depression by inhibiting the protein that transports serotonin, a neurotransmitter involved in sleep and depression, reports the Journal of the American Medical Association (JAMA) via Science Daily. But serotonin may also be associated with an increased rate of bone loss in older men and women, according to two new JAMA articles. And some data suggest that SSRIs may interfere with the function of osteoclasts and osteoblasts, the cells responsible for the regular breaking down and rebuilding of bone in the body. . . So, there’s a choice for you. Depression or broken bones or both. How about looking for the root cause of the depression, not just the (dubious) chemistry? –JULIA WHITTY